Loading...
Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
Dyslipidemia is one of the most common adverse effects in schizophrenia patients treated with antipsychotics. However, there are no established effective treatments. In this study, data were pooled from two randomized, placebo-controlled trials, which were originally designed to examine the efficacy...
Na minha lista:
| Udgivet i: | Mol Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5078852/ https://ncbi.nlm.nih.gov/pubmed/26809842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2015.221 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|